RTSNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Retension Pharmaceuticals, Inc.
$16.33+2.26 (+16.06%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Analysis
Not enough annual history yet
Analysis needs at least two fiscal years of reported financials for Retension Pharmaceuticals.